Azitromitsin (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Azitromitsin" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

22nih.gov

4^th place

7^th place

15doi.org

2^nd place

3^rd place

6cochranelibrary.com

low place

1,425^th place

2drugs.com

399^th place

440^th place

2archive.org

6^th place

8^th place

2fda.gov

447^th place

745^th place

1cdc.gov

218^th place

199^th place

1chestnet.org

low place

archive.org

„Life-threatening bradyarrhythmia after massive azithromycin overdose“. Pharmacotherapy. 26-jild, № 1. January 2006. 147–50-bet. doi:10.1592/phco.2006.26.1.147. PMID 16506357.
Disposition of Toxic Drugs and Chemicals in Man, 8th, Foster City, CA: Biomedical Publications, 2008 — 132–133 bet.

cdc.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

chestnet.org

journal.chestnet.org

„Macrolides for the treatment of chronic sinusitis, asthma, and COPD“. Chest. 125-jild, № 2 Suppl. February 2004. 52S–60S, quiz 60S-61S-bet. doi:10.1378/chest.125.2_suppl.52S. PMID 14872001.

cochranelibrary.com

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

doi.org

„Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly“. The American Journal of Medicine. 128-jild, № 12. December 2015. 1362.e1–6-bet. doi:10.1016/j.amjmed.2015.07.032. PMID 26291905.
„Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults“. Clinical Infectious Diseases. 44 Suppl 2-jild. March 2007. S27-72-bet. doi:10.1086/511159. PMID 17278083. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Interventions for trachoma trichiasis“. The Cochrane Database of Systematic Reviews. 11-jild, № 11. November 2015. CD004008-bet. doi:10.1002/14651858.CD004008.pub3. PMC 4661324. PMID 26568232.
„Clinical practice guideline (update): adult sinusitis“. Otolaryngology–Head and Neck Surgery. 152-jild, № 2 Suppl. April 2015. S1–S39-bet. doi:10.1177/0194599815572097. PMID 25832968. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Preventing COPD exacerbations with macrolides: a review and budget impact analysis“. Respiratory Medicine. 107-jild, № 5. May 2013. 637–48-bet. doi:10.1016/j.rmed.2012.12.019. PMID 23352223.
„Macrolides for the treatment of chronic sinusitis, asthma, and COPD“. Chest. 125-jild, № 2 Suppl. February 2004. 52S–60S, quiz 60S-61S-bet. doi:10.1378/chest.125.2_suppl.52S. PMID 14872001.
„Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases“. European Journal of Clinical Pharmacology. 68-jild, № 5. May 2012. 479–503-bet. doi:10.1007/s00228-011-1161-x. PMID 22105373.
„Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics“. Mediators of Inflammation. 2012-jild. 2012. 584262-bet. doi:10.1155/2012/584262. PMC 3388425. PMID 22778497.
„Azithromycin anaphylaxis in children“. International Journal of Immunopathology and Pharmacology. 27-jild, № 1. 2014. 121–6-bet. doi:10.1177/039463201402700116. PMID 24674687.
„Life-threatening bradyarrhythmia after massive azithromycin overdose“. Pharmacotherapy. 26-jild, № 1. January 2006. 147–50-bet. doi:10.1592/phco.2006.26.1.147. PMID 16506357.
„Azithromycin and the risk of cardiovascular death“. The New England Journal of Medicine. 366-jild, № 20. May 2012. 1881–90-bet. doi:10.1056/NEJMoa1003833. PMC 3374857. PMID 22591294.
„Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection“. J Clin Invest. 121-jild, № 9. Sep 2011. 3554–63-bet. doi:10.1172/JCI46095. PMC 3163956. PMID 21804191.
„Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial“. International Journal of Antimicrobial Agents. 56-jild, № 1. July 2020. 105949-bet. doi:10.1016/j.ijantimicag.2020.105949. PMID 32205204. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options“. Open Forum Infectious Diseases. 7-jild, № 4. April 2020. ofaa105-bet. doi:10.1093/ofid/ofaa105. PMID 32284951.
„Rethinking the role of hydroxychloroquine in the treatment of COVID-19“. FASEB Journal. 34-jild, № 5. May 2020. 6027–6037-bet. doi:10.1096/fj.202000919. PMID 32350928. {{cite magazine}}: Invalid |display-authors=6 (yordam)

drugs.com

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.
{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

fda.gov

accessdata.fda.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

fda.gov

{{Veb manbasi}} andozasidan foydalanishda sarlavha= parametrini belgilashingiz kerak. „{{{title}}}“.

nih.gov

pubmed.ncbi.nlm.nih.gov

„Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly“. The American Journal of Medicine. 128-jild, № 12. December 2015. 1362.e1–6-bet. doi:10.1016/j.amjmed.2015.07.032. PMID 26291905.
„Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults“. Clinical Infectious Diseases. 44 Suppl 2-jild. March 2007. S27-72-bet. doi:10.1086/511159. PMID 17278083. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Interventions for trachoma trichiasis“. The Cochrane Database of Systematic Reviews. 11-jild, № 11. November 2015. CD004008-bet. doi:10.1002/14651858.CD004008.pub3. PMC 4661324. PMID 26568232.
„Clinical practice guideline (update): adult sinusitis“. Otolaryngology–Head and Neck Surgery. 152-jild, № 2 Suppl. April 2015. S1–S39-bet. doi:10.1177/0194599815572097. PMID 25832968. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„AAP releases guideline on diagnosis and management of acute bacterial sinusitis in children one to 18 years of age“. American Family Physician. 89-jild, № 8. April 2014. 676–81-bet. PMID 24784128.
„AAP, AAFP release guideline on diagnosis and management of acute otitis media“. American Family Physician. 69-jild, № 11. June 2004. 2713–5-bet. PMID 15202704.
„IDSA Updates Guideline for Managing Group A Streptococcal Pharyngitis“. American Family Physician. 88-jild, № 5. September 2013. 338–40-bet. PMID 24010402.
„Preventing COPD exacerbations with macrolides: a review and budget impact analysis“. Respiratory Medicine. 107-jild, № 5. May 2013. 637–48-bet. doi:10.1016/j.rmed.2012.12.019. PMID 23352223.
„Macrolides for the treatment of chronic sinusitis, asthma, and COPD“. Chest. 125-jild, № 2 Suppl. February 2004. 52S–60S, quiz 60S-61S-bet. doi:10.1378/chest.125.2_suppl.52S. PMID 14872001.
„Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases“. European Journal of Clinical Pharmacology. 68-jild, № 5. May 2012. 479–503-bet. doi:10.1007/s00228-011-1161-x. PMID 22105373.
„Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics“. Mediators of Inflammation. 2012-jild. 2012. 584262-bet. doi:10.1155/2012/584262. PMC 3388425. PMID 22778497.
„Azithromycin anaphylaxis in children“. International Journal of Immunopathology and Pharmacology. 27-jild, № 1. 2014. 121–6-bet. doi:10.1177/039463201402700116. PMID 24674687.
„Life-threatening bradyarrhythmia after massive azithromycin overdose“. Pharmacotherapy. 26-jild, № 1. January 2006. 147–50-bet. doi:10.1592/phco.2006.26.1.147. PMID 16506357.
„Azithromycin and the risk of cardiovascular death“. The New England Journal of Medicine. 366-jild, № 20. May 2012. 1881–90-bet. doi:10.1056/NEJMoa1003833. PMC 3374857. PMID 22591294.
„Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection“. J Clin Invest. 121-jild, № 9. Sep 2011. 3554–63-bet. doi:10.1172/JCI46095. PMC 3163956. PMID 21804191.
„Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial“. International Journal of Antimicrobial Agents. 56-jild, № 1. July 2020. 105949-bet. doi:10.1016/j.ijantimicag.2020.105949. PMID 32205204. {{cite magazine}}: Invalid |display-authors=6 (yordam)
„Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options“. Open Forum Infectious Diseases. 7-jild, № 4. April 2020. ofaa105-bet. doi:10.1093/ofid/ofaa105. PMID 32284951.
„Rethinking the role of hydroxychloroquine in the treatment of COVID-19“. FASEB Journal. 34-jild, № 5. May 2020. 6027–6037-bet. doi:10.1096/fj.202000919. PMID 32350928. {{cite magazine}}: Invalid |display-authors=6 (yordam)

ncbi.nlm.nih.gov

„Interventions for trachoma trichiasis“. The Cochrane Database of Systematic Reviews. 11-jild, № 11. November 2015. CD004008-bet. doi:10.1002/14651858.CD004008.pub3. PMC 4661324. PMID 26568232.
„Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics“. Mediators of Inflammation. 2012-jild. 2012. 584262-bet. doi:10.1155/2012/584262. PMC 3388425. PMID 22778497.
„Azithromycin and the risk of cardiovascular death“. The New England Journal of Medicine. 366-jild, № 20. May 2012. 1881–90-bet. doi:10.1056/NEJMoa1003833. PMC 3374857. PMID 22591294.
„Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection“. J Clin Invest. 121-jild, № 9. Sep 2011. 3554–63-bet. doi:10.1172/JCI46095. PMC 3163956. PMID 21804191.